Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function

Nature

Volumn 401, Issue 6755, 1999, Pages 808-811

  Law, Debbie A ^a   DeGuzman, Francis R ^a   Heiser, Patrick ^a   Ministri Madrid, Kathleen ^a   Killeen, Nigel ^b   Phillips, David R ^a  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; PHENYLALANINE; TYROSINE;

ANIMAL CELL; ARTICLE; BLOOD CLOT RETRACTION; CALCIUM MOBILIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

AMINO ACID MOTIFS; ANIMALS; BLEEDING TIME; BLOOD COAGULATION; BLOOD PLATELETS; CLONING, MOLECULAR; CYTOPLASM; FIBRINOGEN; MICE; PHOSPHORYLATION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POINT MUTATION; SIGNAL TRANSDUCTION; TYROSINE;

ANIMALIA;

EID: 0033592610     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/44599     Document Type: Article

References (24)

1. Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25 (1992).
2. Shattil, S., Kashiwagi H. & Pampori, N. Integrin signaling: the platelet paradigm. Blood 91, 1-14 (1998).
3. Phillips, D. R., Charo, I. F. & Scarborough, R. M. GPIIb-IIIa: the responsive integrin. Cell 65, 359-362 (1991).
4. Yamaguchi, K. et al. Flow cytometric analysis of changes in cytoskeletal proteins during platelet destruction and activation using a monoclonal antibody against platelet myosin. Am. J. Hematol. 44, 106-111 (1993).
5. Clark, E. A., Shattil, S. J., Ginsberg, M. H., Bolen, J. & Brugge, J. S. Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin αIIbβ3. J. Biol. Chem. 269, 28859-28864 (1994).
6. Lipfert, L. et al. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J. Cell. Biol. 119, 905-912 (1992).
7. Law, D. A., Nannizzi-Alaimo, L. & Phillips, D. R. Outside-in integrin signal transduction. αIIbβ3-(GP IIb IIIa) tyrosine phosphorylation induced by platelet aggregation. J. Biol. Chem. 271, 10811-10815 (1996).
8. Phillips, D. R., Jennings, L. K. & Edwards, H. H. Identification of membrane proteins mediating the interaction of human platelets. J. Cell. Biol. 86, 77-86 (1980).
9. van der Geer, P. et al. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. Curr. Biol. 5, 404-412 (1995).
10. Jenkins, A. et al. Tyrosine phosphorylation of the β3 cytoplasmic domain mediates integrincytoskeletal interactions. J. Biol. Chem. 273, 13878-13885 (1998).
11. Guinto, E. R. et al. Unexpected crucial role of residue 225 in serine proteases. Proc. Natl Acad. Sci. USA 96, 1852-1857 (1999).
12. Filardo, E. J., Brooks, P. C., Deming, S. L., Damsky, C. & Cheresh, D. A. Requirement of the NPXY motif in the integrin β3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J. Cell. Biol. 30, 441-450 (1995).
13. Romzek, N. C. et al. Use of a β1 integral-deficient human T cell to identify β1 integrin cytoplasmic domain sequences critical for integrin function. Mol. Biol. Cell 9, 2715-2777 (1998).
14. Ylanne, J. et al. Distinct functions of integrin α and β subunit cytoplasmic domains in cell spreading and formation of focal adhesions. J. Cell. Biol. 122, 223-233 (1993).
15. Blystone, S. D., Williams, M. P., Slater, S. E. & Brown, E. J. Requirement of integrin β3 tyrosine 747 for β3 tyrosine phosphorylation and regulation of αvβ3 avidity. J. Biol. Chem. 272, 28757-28761 (1997).
16. Fox, J. E. et al. On the role of the platelet membrane skeleton in mediating signal transduction. Association of GP IIb-IIIa, pp60c-src, pp62c-yes, and the p21 ras GTPase-activating protein with the membrane skeleton. J. Biol. Chem. 268, 25973-25984 (1993).
17. Hodivala-Dilke, K. M. et al. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103, 229-238 (1999).
18. Coller, B. S. Platelets and thrombolytic therapy. N. Engl. J. Med. 322, 33-42 (1990).
19. Chen, Y. P. et al. Ser-752→Pro mutation in the cytoplasmic domain of integrin β3 subunit and defective activation of platelet integrin αIIb β;3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc.f Natl Acad. Sci. USA 89, 10169-10173 (1992).
20. Chen, Y. P., O'Toole, T. E., Ylanne, J., Rosa, J. P. & Ginsberg, M. H. A point mutation in the integrin β3 cytoplasmic domain (S752→P) impairs bidirectional signaling through αIIbβ3 (platelet glycoprotein IIb-IIIa). Blood 84, 1857-1865 (1994).
21. Williams, M. J., Hughes, P. E., O'Toole, T. E. & Ginsberg, M. H. The inner world of cell adhesion:integrin cytoplasmic domains. Trends Cell Biol. 4, 109-112 (1994).
22. Fitzgerald, L. A., Steiner, B., Rall, S. C. Jr, Lo, S. S. & Phillips, D. R. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA done. Identity with platelet glycoprotein IIIa and similarity to "integrin". J. Biol. Chem. 262, 3936-3939 (1987).
23. Dymecki, S. M. Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc. Natl Acad. Sci. USA 93, 6191-6196 (1996).
24. Law, D. A. et al. Genetic and pharmacologic analyses of Syk function in αIIbβ3 signaling in platelets. Blood 93, 2645-2652 (1999).